HNL is also differentially expressed in various tumors, with higher levels in adenocarcinomas of the lung, colon, and pancreas, and negative immunostaining for HNL in lymphomas and thymic tumors (Friedl et al., 1999). Here, LCN2 is linked to thymus neoplasm.